Collaborations

Collaboration is at the heart of our mission to advance breakthrough cancer research. We recognize that meaningful progress in cancer treatment and diagnostics requires the collective expertise of scientists, clinicians, and research institutions worldwide.

We currently have collaborations with a number of partners including Moffitt, Sylvester, MD Anderson, AdventHealth and The Medical College of Georgia.

We actively seek partnerships with researchers and institutions who share our commitment to identifying novel cancer-specific targets and developing innovative immunotherapies. Whether you specialize in molecular oncology, biomarker discovery, drug development, or related fields, we welcome opportunities to collaborate on projects that drive meaningful advancements in cancer treatment.

Our team at CAI works closely with leading academic and medical institutions, leveraging cutting-edge technology and data-driven research to explore new frontiers in cancer biology. By joining forces, we can accelerate the translation of research discoveries into life-changing therapies.

If you or your institution are interested in working with us, we encourage you to reach out. Together, we can make significant strides toward more effective and targeted cancer treatments.

Contact us to explore collaboration opportunities and be a part of groundbreaking cancer research.